Essential thrombocytosis epidemiology and demographics: Difference between revisions
(Created page with "{{Essential thrombocytosis}} {{CMG}} ==Overview== ==References== {{reflist|2}} Category:Disease Category:Types of cancer Category:Hematology [[Category:Oncolog...") |
|||
| Line 3: | Line 3: | ||
==Overview== | ==Overview== | ||
==Epidemiology== | |||
Essential thrombocytosis is diagnosed at a rate of about 2 to 3 per 100,000 individuals annually.<ref>{{cite journal | author = Mesa R, Silverstein M, Jacobsen S, Wollan P, Tefferi A | title = Population-based incidence and survival figures in essential thrombocythemia and agnogenic myeloid metaplasia: an Olmsted County Study, 1976-1995. | journal = Am J Hematol | volume = 61 | issue = 1 | pages = 10-5 | year = 1999 | id = PMID 10331505}}</ref><ref>{{cite journal | author = Kutti J, Ridell B | title = Epidemiology of the myeloproliferative disorders: essential thrombocythaemia, polycythaemia vera and idiopathic myelofibrosis. | journal = Pathol Biol (Paris) | volume = 49 | issue = 2 | pages = 164-6 | year = 2001 | id = PMID 11317963}}</ref> The disease usually affects middle aged to elderly individuals, with an average age at diagnosis of 50-60 years, although it can affect children and young adults as well.<ref>Hoffman: Hematology: Basic Principles and Practice, 4th ed., 2005 Churchill Livingstone, Chapter 71.</ref> | |||
==References== | ==References== | ||
Revision as of 22:01, 20 January 2012
|
Essential thrombocytosis Microchapters |
|
Differentiating Essential thrombocytosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Essential thrombocytosis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Essential thrombocytosis epidemiology and demographics |
|
FDA on Essential thrombocytosis epidemiology and demographics |
|
CDC on Essential thrombocytosis epidemiology and demographics |
|
Essential thrombocytosis epidemiology and demographics in the news |
|
Blogs on Essential thrombocytosis epidemiology and demographics |
|
Risk calculators and risk factors for Essential thrombocytosis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Epidemiology
Essential thrombocytosis is diagnosed at a rate of about 2 to 3 per 100,000 individuals annually.[1][2] The disease usually affects middle aged to elderly individuals, with an average age at diagnosis of 50-60 years, although it can affect children and young adults as well.[3]
References
- ↑ Mesa R, Silverstein M, Jacobsen S, Wollan P, Tefferi A (1999). "Population-based incidence and survival figures in essential thrombocythemia and agnogenic myeloid metaplasia: an Olmsted County Study, 1976-1995". Am J Hematol. 61 (1): 10–5. PMID 10331505.
- ↑ Kutti J, Ridell B (2001). "Epidemiology of the myeloproliferative disorders: essential thrombocythaemia, polycythaemia vera and idiopathic myelofibrosis". Pathol Biol (Paris). 49 (2): 164–6. PMID 11317963.
- ↑ Hoffman: Hematology: Basic Principles and Practice, 4th ed., 2005 Churchill Livingstone, Chapter 71.